| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.22 | 7e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |